| abstract |
The present invention provides methods of treating or preventing autoimmune diseases with spiro 2,4-pyrimidinediamine compounds of Formula (I), as well as methods of treating, preventing or ameliorating symptoms associated with such diseases. Specific examples of autoimmune diseases that can be treated or prevented with the compounds include rheumatoid arthritis and/or its associated symptoms, systemic lupus erythematosis and/or its associated symptoms and multiple sclerosis and/or its associated symptoms. |